CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules
Clinical trial NCT06117085 · COMPLETED
Trial details
- NCT number
- NCT06117085
- Sponsor
- Pulse Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2024-11-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.